• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设立用于高危冠状动脉血运重建的正式多学科心脏团队。

Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.

作者信息

Potluri Srinivasa, Sawhney Rahul, Dorton Cody, McCullough Kyle, Moubarak Ghadi, Shih Emily, Christensen Jared, DiMaio J Michael, Al-Azizi Karim, Dib Chadi, Sayfo Sameh, Szerlip Molly, Thomas Sibi, Levy Alfred, Hutcheson Kelly, Carranza Melissa, Douthit Samantha, Pettijohn Trent, Ryan William, Mack Michael

机构信息

Department of Cardiology, Baylor Scott & White The Heart Hospital - Plano, Plano, Texas, USA.

Baylor Scott & White Research Institute, Plano, Texas, USA.

出版信息

Proc (Bayl Univ Med Cent). 2024 Nov 22;38(1):28-33. doi: 10.1080/08998280.2024.2426925. eCollection 2025.

DOI:10.1080/08998280.2024.2426925
PMID:39712420
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11657062/
Abstract

INTRODUCTION

The heart team approach is now the standard of care for patients with complex coronary artery disease; however, the definition of a heart team is variable. We embarked on a project to create an extended, multidisciplinary heart team to evaluate patients we deemed high risk for coronary revascularization. In doing so, we created a new service, workflow, and paradigm.

METHODS

Herein, we describe the process through which we created our high-risk percutaneous coronary intervention team, our criteria for determining risk, our process for evaluating these patients, and quality assurance. Additionally, we describe the design of our prospective study assessing 200 patients with complex coronary artery disease. The primary outcomes include the final heart team revascularization decision, all-cause mortality, major adverse cardiac events, acute kidney injury, postintervention bleeding, and length of stay.

CONCLUSION

Establishing a multidisciplinary heart team may help with complex and high-risk patient and family scenarios and potentially improve patient outcomes. A study has been initiated to test this hypothesis formally.

摘要

引言

心脏团队模式现已成为复杂冠状动脉疾病患者的标准治疗方式;然而,心脏团队的定义并不统一。我们开展了一个项目,组建了一个扩大的多学科心脏团队,以评估我们认为冠状动脉血运重建高风险的患者。在此过程中,我们创建了一项新服务、工作流程和模式。

方法

在此,我们描述创建高风险经皮冠状动脉介入治疗团队的过程、确定风险的标准、评估这些患者的流程以及质量保证。此外,我们描述了评估200例复杂冠状动脉疾病患者的前瞻性研究设计。主要结局包括心脏团队最终的血运重建决策、全因死亡率、主要不良心脏事件、急性肾损伤、干预后出血以及住院时间。

结论

建立多学科心脏团队可能有助于应对复杂和高风险的患者及家庭情况,并有可能改善患者结局。现已启动一项研究以正式检验这一假设。

相似文献

1
Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.设立用于高危冠状动脉血运重建的正式多学科心脏团队。
Proc (Bayl Univ Med Cent). 2024 Nov 22;38(1):28-33. doi: 10.1080/08998280.2024.2426925. eCollection 2025.
2
Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation.多学科心脏团队治疗复杂冠状动脉疾病:单中心临床报告。
J Am Heart Assoc. 2020 Apr 21;9(8):e014738. doi: 10.1161/JAHA.119.014738. Epub 2020 Apr 20.
3
Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease.血运重建心脏团队建议作为复杂冠状动脉疾病患者冠状动脉血运重建适当使用标准的辅助措施。
Catheter Cardiovasc Interv. 2016 Oct;88(4):E103-E112. doi: 10.1002/ccd.26276. Epub 2015 Nov 3.
4
The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions.冠状动脉血运重建的现状:冠状动脉旁路移植术与经皮冠状动脉介入治疗。
Curr Cardiol Rep. 2024 Sep;26(9):919-933. doi: 10.1007/s11886-024-02090-x. Epub 2024 Jul 10.
5
Heart Team/Guidelines Discordance Is Associated With Increased Mortality: Data From a National Survey of Revascularization in Patients With Complex Coronary Artery Disease.心脏团队/指南不一致与死亡率增加相关:一项复杂冠状动脉疾病患者血运重建全国调查的数据。
Circ Cardiovasc Interv. 2021 Jan;14(1):e009686. doi: 10.1161/CIRCINTERVENTIONS.120.009686. Epub 2021 Jan 11.
6
The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) Registry: Rationale and Design.经皮血运重建术治疗多支血管病变或左主干冠状动脉疾病(OPTIMUM)手术禁忌患者的结局:原理与设计。
Cardiovasc Revasc Med. 2022 Aug;41:83-91. doi: 10.1016/j.carrev.2022.01.008. Epub 2022 Jan 31.
7
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.接受冠状动脉介入治疗后接受双联抗血小板治疗和三联治疗的患者的出血风险:ADAPTT 回顾性基于人群的队列研究。
Health Technol Assess. 2023 May;27(8):1-257. doi: 10.3310/MNJY9014.
8
Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study.实施多学科心脏团队方法对复杂冠状动脉疾病患者进行血运重建的安全性和有效性:一项观察性队列研究。
JAMA Surg. 2014 Nov;149(11):1109-12. doi: 10.1001/jamasurg.2014.2059.
9
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在冠状动脉血运重建中的比较:一项系统评价。
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
10
What is the optimal revascularization technique for isolated disease of the left anterior descending artery: minimally invasive direct coronary artery bypass or percutaneous coronary intervention?对于单纯左前降支病变,最佳的血运重建技术是什么:微创直接冠状动脉旁路移植术还是经皮冠状动脉介入治疗?
Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):144-8. doi: 10.1093/icvts/ivu076. Epub 2014 Mar 25.

引用本文的文献

1
Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease.多学科心脏团队指导下的复杂冠状动脉疾病管理后的长期生存情况。
Proc (Bayl Univ Med Cent). 2025 Jun 20;38(5):589-597. doi: 10.1080/08998280.2025.2516981. eCollection 2025.

本文引用的文献

1
Is it time to refresh the heart team? New paradigms for shared decision making.是时候更新心脏团队了吗?共享决策的新范式。
Heart. 2021 Apr;107(8):674-681. doi: 10.1136/heartjnl-2020-316588. Epub 2020 Oct 27.
2
Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation.多学科心脏团队治疗复杂冠状动脉疾病:单中心临床报告。
J Am Heart Assoc. 2020 Apr 21;9(8):e014738. doi: 10.1161/JAHA.119.014738. Epub 2020 Apr 20.
3
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2014年美国心脏病学会/美国心脏协会/美国胸外科医师协会/预防心血管护理协会/心血管造影和介入学会/胸外科医师学会对稳定型缺血性心脏病患者诊断和管理指南的重点更新:美国心脏病学会/美国心脏协会实践指南工作组、美国胸外科医师协会、预防心血管护理协会、心血管造影和介入学会及胸外科医师学会的报告
J Thorac Cardiovasc Surg. 2015 Mar;149(3):e5-23. doi: 10.1016/j.jtcvs.2014.11.002. Epub 2014 Nov 7.
4
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).高危经皮冠状动脉介入治疗:从 NCDR(国家心血管数据注册中心)1208137 例手术中得出的注重高危患者的死亡率风险预测结果。
JACC Cardiovasc Interv. 2013 Aug;6(8):790-9. doi: 10.1016/j.jcin.2013.03.020.
5
A crucial factor in shared decision making: the team approach.共同决策中的一个关键因素:团队协作方法。
Lancet. 2011 May 28;377(9780):1836. doi: 10.1016/S0140-6736(11)60775-7.
6
Guidelines on myocardial revascularization.心肌血运重建指南。
Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277. Epub 2010 Aug 29.
7
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry.当代经皮冠状动脉介入治疗的死亡率风险预测:来自国家心血管数据注册中心 588398 例手术的结果。
J Am Coll Cardiol. 2010 May 4;55(18):1923-32. doi: 10.1016/j.jacc.2010.02.005.